JPWO2020209350A1 - - Google Patents

Info

Publication number
JPWO2020209350A1
JPWO2020209350A1 JP2021513709A JP2021513709A JPWO2020209350A1 JP WO2020209350 A1 JPWO2020209350 A1 JP WO2020209350A1 JP 2021513709 A JP2021513709 A JP 2021513709A JP 2021513709 A JP2021513709 A JP 2021513709A JP WO2020209350 A1 JPWO2020209350 A1 JP WO2020209350A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021513709A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020209350A1 publication Critical patent/JPWO2020209350A1/ja
Priority to JP2025023376A priority Critical patent/JP2025081466A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021513709A 2019-04-12 2020-04-10 Pending JPWO2020209350A1 (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025023376A JP2025081466A (ja) 2019-04-12 2025-02-17 糖尿病治療用口腔内速崩壊錠

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019076376 2019-04-12
PCT/JP2020/016062 WO2020209350A1 (ja) 2019-04-12 2020-04-10 糖尿病治療用口腔内速崩壊錠

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025023376A Division JP2025081466A (ja) 2019-04-12 2025-02-17 糖尿病治療用口腔内速崩壊錠

Publications (1)

Publication Number Publication Date
JPWO2020209350A1 true JPWO2020209350A1 (enrdf_load_stackoverflow) 2020-10-15

Family

ID=72751341

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021513709A Pending JPWO2020209350A1 (enrdf_load_stackoverflow) 2019-04-12 2020-04-10
JP2025023376A Pending JP2025081466A (ja) 2019-04-12 2025-02-17 糖尿病治療用口腔内速崩壊錠

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025023376A Pending JP2025081466A (ja) 2019-04-12 2025-02-17 糖尿病治療用口腔内速崩壊錠

Country Status (2)

Country Link
JP (2) JPWO2020209350A1 (enrdf_load_stackoverflow)
WO (1) WO2020209350A1 (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022135317A (ja) * 2021-03-05 2022-09-15 日医工株式会社 リナグリプチン製剤
JP2022184669A (ja) * 2021-06-01 2022-12-13 日本ジェネリック株式会社 テネリグリプチン含有医薬組成物
JPWO2024232216A1 (enrdf_load_stackoverflow) * 2023-05-10 2024-11-14

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006088129A1 (ja) * 2005-02-18 2006-08-24 Mitsubishi Pharma Corporation プロリン誘導体の塩、またはその溶媒和物、及びその製造方法
WO2011019043A1 (ja) * 2009-08-11 2011-02-17 大日本住友製薬株式会社 ２種以上の粒子を含有する口腔内速崩壊錠
WO2011074660A1 (ja) * 2009-12-18 2011-06-23 田辺三菱製薬株式会社 溶出安定性製剤
WO2016104643A1 (ja) * 2014-12-25 2016-06-30 田辺三菱製薬株式会社 糖尿病治療用固形製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04257525A (ja) * 1991-02-08 1992-09-11 Shin Etsu Chem Co Ltd 易崩壊性パンクレアチン顆粒剤
CN104644580A (zh) * 2013-11-25 2015-05-27 天津市汉康医药生物技术有限公司 一种替格列汀的药物组合物
WO2015132679A1 (en) * 2014-03-05 2015-09-11 Glenmark Pharmaceuticals Ltd Teneligliptin compositions
ES2928347T3 (es) * 2015-10-07 2022-11-17 Steerlife India Private Ltd Composiciones de comprimidos de disgregación rápida de inhibidores de DPP-IV con bajo contenido mineral
TW201831473A (zh) * 2017-02-03 2018-09-01 印度商格倫馬克製藥有限公司 特力利汀的草酸鹽及其溶劑合物、中間體、製備方法及其標記物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006088129A1 (ja) * 2005-02-18 2006-08-24 Mitsubishi Pharma Corporation プロリン誘導体の塩、またはその溶媒和物、及びその製造方法
WO2011019043A1 (ja) * 2009-08-11 2011-02-17 大日本住友製薬株式会社 ２種以上の粒子を含有する口腔内速崩壊錠
WO2011074660A1 (ja) * 2009-12-18 2011-06-23 田辺三菱製薬株式会社 溶出安定性製剤
WO2016104643A1 (ja) * 2014-12-25 2016-06-30 田辺三菱製薬株式会社 糖尿病治療用固形製剤

Also Published As

Publication number Publication date
WO2020209350A1 (ja) 2020-10-15
JP2025081466A (ja) 2025-05-27

Similar Documents

Publication Publication Date Title
BR112019017762A2 (enrdf_load_stackoverflow)
BR112021017339A2 (enrdf_load_stackoverflow)
BR112021018450A2 (enrdf_load_stackoverflow)
BR112021017637A2 (enrdf_load_stackoverflow)
BR112021017892A2 (enrdf_load_stackoverflow)
BR112019016141A2 (enrdf_load_stackoverflow)
BR112021017939A2 (enrdf_load_stackoverflow)
BR112021017738A2 (enrdf_load_stackoverflow)
BR112021017782A2 (enrdf_load_stackoverflow)
BR112021008711A2 (enrdf_load_stackoverflow)
BR112021016821A2 (enrdf_load_stackoverflow)
BR112021018452A2 (enrdf_load_stackoverflow)
BR112021017728A2 (enrdf_load_stackoverflow)
BR112019016142A2 (enrdf_load_stackoverflow)
BR112019016138A2 (enrdf_load_stackoverflow)
BR112021017234A2 (enrdf_load_stackoverflow)
BR112021018168A2 (enrdf_load_stackoverflow)
BR112021017703A2 (enrdf_load_stackoverflow)
BR112021017732A2 (enrdf_load_stackoverflow)
BR112021015080A2 (enrdf_load_stackoverflow)
BR112021012348A2 (enrdf_load_stackoverflow)
BR112021018250A2 (enrdf_load_stackoverflow)
BR112021017355A2 (enrdf_load_stackoverflow)
BR112021018093A2 (enrdf_load_stackoverflow)
BR112021017173A2 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240625

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240822

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20241119

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20250210